Sonexa Therapeutics
San Diego
About Sonexa Therapeutics
Sonexa Therapeutics, Inc., a pharmaceutical company, engages in the development of therapeutics drugs for the treatment of Alzheimer's disease and related disorders. It develops ST101, a small and orally active molecule compound that penetrates the blood-brain-barrier. The company was incorporated in 2007 and is based in San Diego, California.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $41.2M
- Last round: Debt Financing (Aug 2012)
- Website: sonexa.com
- Phone: 858-356-6250
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/sonexa-therapeutics-3539659 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.